article thumbnail

Biotech R&D Platform Benchling Closes $100M at $6B Valuation

HIT Consultant

Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. As biotechnology companies come under increased pressure to deliver breakthroughs, they are turning to modern software to digitize all their scientific processes and centralize their data. Recent Traction/Milestones.

article thumbnail

Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing

Bill Of Health

Although Grossbard and Bourzat deny the allegations, these accounts were vetted by leading news organizations, withstood legal threats from Grossbard and Bourzat, and have been substantiated by a growing body of consistent and corroborated accounts by survivors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Correctional Sleep: Where Litigation Falls Short and Where Research, Policymaking are Needed

Bill Of Health

So while typical mitigation strategies including correctional vaccination campaigns and social distancing remain necessary, effective correctional pandemic mitigations strategies must also account for poor sleep. To address the paucity of sleep research in U.S. Jolin is an A.B.

article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

– The larger transactions in the quarter were, once again, transactions occurring in the Pharmaceutical and Biotechnology subsectors. . – Overall transaction value of deals announced and/or closed in Q2 2022 was $26 billion versus $31 billion in Q2 2021 and $65 billion in Q4 2021.

article thumbnail

Perspectives on Data Privacy for Direct-to-Consumer Health Apps

Bill Of Health

She previously served as a Research Fellow in Medicine, Artificial Intelligence, and Law at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School for the Project on Precision Medicine, Artificial Intelligence, and the Law ( PMAIL ).

article thumbnail

Uber Health Hires First Chief Medical Officer, Aledade’s New CEO, Other Digital Health Appointments

HIT Consultant

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.

article thumbnail

Why Congress should not mandate disclosure of drug development costs

Healthcare ECONOMIST

It may appear on financial statements that successful pharmaceutical make outsized profits, but these figures must also take into account that many pharmaceutical firms have drugs that fail and the companies go out of business. The bigger issue, however, is that of survival bias. Information on cost can promote innovation.